BioLine RX Ltd (NASDAQ:BLRX)

0.3548
Delayed Data
As of Jun 19
 +0.008 / +2.31%
Today’s Change
0.31
Today|||52-Week Range
1.84
-18.87%
Year-to-Date

Today’s Trading

Previous close0.35
Today’s open0.34
Day’s range0.34 - 0.37
Volume682,279
Average volume (3 months)996,412
Market cap$50.8M
Data as of 3:53pm ET, 06/19/2019

Growth & Valuation

Earnings growth (last year)+22.47%
Earnings growth (this year)+19.05%
Earnings growth (next 5 years)-25.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.96

Competitors

 Today’s
change
Today’s
% change
OPNTOpiant Pharmaceutica...-0.13-0.97%
ZFGNZafgen Inc+0.01+0.71%
ISEEIVERIC bio Inc-0.02-1.52%
--Innovative Pharmaceu...-0.00-2.63%
Data as of 4:00pm ET, 06/19/2019

Financials

Next reporting dateAugust 7, 2019
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$22.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Philip Adam Serlin
Chief Financial Officer
Mali Zeevi
Corporate headquarters
Modi'in, Tel Aviv

Forecasts